Blockade of PPAR-γ signaling also abolished the ability of asperosaponin VI to suppress pro-inflammatory cytokines and elevate anti-inflammatory cytokines in the hippocampus of CMS mice (Fig. 5F and G). This evidence concerns the gene PPARG and congenital myasthenic syndrome.